Articles | Behavioral Healthcare Magazine Skip to content Skip to navigation

Articles

'Heartless' Senate bill slashes Medicaid, offers $2 billion in opioid funds

June 22, 2017     Julie Miller, Editor in Chief

President Trump said the Senate bill should have more “heart,” but industry experts reviewing the draft after its release today don’t believe it contains any heart at all. For one, the bill would end Medicaid expansion in 2020.

Insurers not providing sufficient evidence of parity act compliance

June 22, 2017     Tom Valentino, Senior Editor

A recently analysis finds insurers are not providing consumers or state regulators with adequate documentation about their plans’ mental health and addiction treatment benefits.

CleanSlate portfolio grows with demand for MAT

June 15, 2017     Julie Miller, Editor in Chief

CleanSlate's growth is driven by an emerging demand for medication-assisted treatment services as well as market opportunity. With backing from growth-equity fund Apple Tree Partners, the organization is primarily expanding through new center openings.

Opioid-related treatment approaches vary by region

June 14, 2017     Tom Valentino, Senior Editor

Data released this week by not-for-profit FAIR Health shows significant variation in treatment approaches for opioid-related diagnoses by location.

SAMHSA: Medication treatment for SUD increases significantly

June 12, 2017     Julie Miller, Editor in Chief

According to SAMHSA’s latest Behavioral Health Barometer, between 2011 and 2015, methadone use increased by 16%, and use of buprenorphine more than doubled.

SAMHSA: Medication treatment for SUD increases significantly

June 12, 2017     Julie Miller, Editor in Chief

New bipartisan bill revisits IMD issue

June 7, 2017     Julie Miller, Editor in Chief

The Medicaid Coverage for Addiction Recovery Expansion (CARE) Act would allow Medicaid payment to residential addiction treatment facilities with up to 40 beds—an increase over the current 16 bed limit. It would also allow for treatment services for up to 60 consecutive days.

Need for buprenorphine demonstrated in Medicaid data

June 7, 2017     Julie Miller, Editor in Chief

A new brief from the Urban Institute shows that Medicaid programs nationwide have seen increases in buprenorphine prescriptions since the launch of the Affordable Care Act, but trends are higher in expansion states.

How reversing net neutrality might affect your business

June 6, 2017     Julie Miller, Editor in Chief

One of the largest referral sources for addiction treatment centers is the internet, and that channel could see some changes this year. It’s surprising that more healthcare leaders haven’t weighed in on net neutrality.

Murthy: Opioid crisis solution starts with culture change

May 26, 2017     Alicia Hoisington

Vivek H. Murthy, MD, the former U.S. surgeon general, spoke Thursday at a community forum in Cleveland, highlighting the need for all healthcare providers to rethink addiction.

Behavioral Healthcare Executive wins journalism award

May 26, 2017     BHE Staff

Addiction Professional and Behavioral Healthcare Executive have earned three prestigious awards for excellence in journalism.

Sober fraternity adds collegiate resources

May 25, 2017     Julie Miller, Editor in Chief

The Alpha 180 sober fraternity is emerging in Austin, Texas, designed as a lifestyle support program for those in recovery.

Seniors respond to depression treatment at home

May 24, 2017     Tom Valentino, Senior Editor

A pilot program for delivering treatment to seniors and their caregivers at home and in the patient’s primary language has been shown to reduce depression and anxiety, and improve quality of life.

How effective are PDMPs?

May 24, 2017     Brian Albright

The databases have had clear impact on overprescribing but measuring their impact on overdoses is tricky.

Rumored gutting of ONDCP agenda does not materialize in president's budget plan

May 24, 2017     Gary A. Enos, Contributing Editor

Most core functions of the Office of National Drug Control Policy, including oversight of the Drug-Free Communities Support Program, are preserved in President Trump's fiscal 2018 budget proposal.

NAATP: Consider emerging operational issues

May 23, 2017     Julie Miller, Editor in Chief

In the larger healthcare system, addiction providers have a unique position among the specialty segments. A panel of treatment center CEOs shared their insights on several emerging operational issues at the NAATP annual conference.

TCEM: 5 things to know about fraud investigations

May 19, 2017     BHE Staff

Attorney Anelia Shaheed recently spoke at the Treatment Center Executive & Marketing Retreat, highlighting critical information for every marketer and treatment center leader.

What to do when you receive a subpoena

May 18, 2017     Barrett Howell and Ryan Meyer

Here is a list of do’s and don’ts to follow in responding to federal government investigations of your healthcare organization.

TCEM: Proving value will be the challenge for the future

May 18, 2017     BHE Staff

At the Treatment Center Executive and Marketing Retreat, CEO Doug Tieman recommended that today’s treatment centers begin by prioritizing their revenue path and expansion strategies.

Ethics Survey: Drug testing remains a clinical tug of war

May 18, 2017     Julie Miller, Editor in Chief

Treatment centers must weigh costs and clinical needs when creating policies for patient drug testing. Meanwhile, investors are examining how drug testing fits in the greater scheme of profits and regulatory risks.

Pages